|
| 37270740 | The stability and persistence of symptoms in childhood-onset ADHD. | Eur Child Adolesc Psychiatry | 2024 |
| 37270740 | The stability and persistence of symptoms in childhood-onset ADHD. | Eur Child Adolesc Psychiatry | 2024 |
| 34125637 | Developing Empirical Latent Profiles of Impulsive Aggression and Mood in Youths across Three Outpatient Samples. | J Clin Child Adolesc Psychol | 2023 |
| 35358662 | Narrative Review: Impairing Emotional Outbursts: What They Are and What We Should Do About Them. | J Am Acad Child Adolesc Psychiatry | 2023 |
| 36442043 | Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youth. | Psychol Assess | 2023 |
| 37287230 | Adequacy of Children's Psychopharmacology Services: Variations by Race and Clinical Characteristics. | Psychiatr Serv | 2023 |
| 37437109 | Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study. | J Child Adolesc Psychopharmacol | 2023 |
| 36609931 | Finding a Needed Diagnostic Home for Children with Impulsive Aggression. | Clin Child Fam Psychol Rev | 2023 |
| 37229653 | Reorienting Latent Variable Modeling for Supervised Learning. | Multivariate Behav Res | 2023 |
| 36917024 | Comparing self-reported quality of life in youth with bipolar versus other disorders. | Bipolar Disord | 2023 |
| 36526163 | An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric Trials. | J Am Acad Child Adolesc Psychiatry | 2023 |
| 34125637 | Developing Empirical Latent Profiles of Impulsive Aggression and Mood in Youths across Three Outpatient Samples. | J Clin Child Adolesc Psychol | 2023 |
| 35358662 | Narrative Review: Impairing Emotional Outbursts: What They Are and What We Should Do About Them. | J Am Acad Child Adolesc Psychiatry | 2023 |
| 37287230 | Adequacy of Children's Psychopharmacology Services: Variations by Race and Clinical Characteristics. | Psychiatr Serv | 2023 |
| 37437109 | Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study. | J Child Adolesc Psychopharmacol | 2023 |
| 37229653 | Reorienting Latent Variable Modeling for Supervised Learning. | Multivariate Behav Res | 2023 |
| 36442043 | Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youth. | Psychol Assess | 2023 |
| 36917024 | Comparing self-reported quality of life in youth with bipolar versus other disorders. | Bipolar Disord | 2023 |
| 36609931 | Finding a Needed Diagnostic Home for Children with Impulsive Aggression. | Clin Child Fam Psychol Rev | 2023 |
| 36526163 | An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric Trials. | J Am Acad Child Adolesc Psychiatry | 2023 |
| 33077012 | Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study. | CNS Spectr | 2022 |
| 35394365 | Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. | J Child Adolesc Psychopharmacol | 2022 |
| 35577034 | Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 36282771 | 26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic). | J Child Adolesc Psychopharmacol | 2022 |
| 33998439 | Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM. | CNS Spectr | 2022 |
| 34091008 | Diagnostic Trends and Prescription Patterns in Disruptive Mood Dysregulation Disorder and Bipolar Disorder. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 33077012 | Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study. | CNS Spectr | 2022 |
| 35033635 | Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 35206449 | Physical Activity Levels and Screen Time among Youth with Overweight/Obesity Using Mental Health Services. | Int J Environ Res Public Health | 2022 |
| 35201823 | Diagnostic accuracy of Achenbach scales in detecting youths' substance use disorders. | Psychol Assess | 2022 |
| 34657090 | Suicide Risk Screening in Pediatric Outpatient Neurodevelopmental Disabilities Clinics. | J Dev Behav Pediatr | 2022 |
| 35577034 | Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 35394365 | Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. | J Child Adolesc Psychopharmacol | 2022 |
| 36282771 | 26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic). | J Child Adolesc Psychopharmacol | 2022 |
| 35033635 | Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 35206449 | Physical Activity Levels and Screen Time among Youth with Overweight/Obesity Using Mental Health Services. | Int J Environ Res Public Health | 2022 |
| 35201823 | Diagnostic accuracy of Achenbach scales in detecting youths' substance use disorders. | Psychol Assess | 2022 |
| 34657090 | Suicide Risk Screening in Pediatric Outpatient Neurodevelopmental Disabilities Clinics. | J Dev Behav Pediatr | 2022 |
| 34091008 | Diagnostic Trends and Prescription Patterns in Disruptive Mood Dysregulation Disorder and Bipolar Disorder. | J Am Acad Child Adolesc Psychiatry | 2022 |
| 33998439 | Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM. | CNS Spectr | 2022 |
| 29707999 | An Examination of Blood Cell Membrane Potential as a Diagnostic Test of Attention Deficit Disorder in Children. | J Atten Disord | 2021 |
| 37609560 | An Update on Precision Medicine Advances In Neurodevelopmental Disorders. | Psychiatr Ann | 2021 |
| 32401546 | Evaluating and Validating GBI Mania and Depression Short Forms for Self-Report of Mood Symptoms. | J Clin Child Adolesc Psychol | 2021 |
| 32228725 | Closing the gap: unmet needs of individuals with impulsive aggressive behavior observed in children and adolescents. | CNS Spectr | 2021 |
| 32338106 | A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD. | J Atten Disord | 2021 |
| 31982581 | Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder. | J Am Acad Child Adolesc Psychiatry | 2021 |
| 34181360 | A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. | J Clin Psychopharmacol | 2021 |
| 33750646 | Once-Daily SPN-812Â 200 and 400Â mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial. | Clin Ther | 2021 |
| 34283918 | Irritability Is Associated with Illness Severity and Anhedonia Is Associated with Functional Impairment Among Depressed Children and Adolescents. | J Child Adolesc Psychopharmacol | 2021 |
| 34232583 | Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients. | J Clin Psychiatry | 2021 |